Compare Corsair Gaming Inc (CRSR) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corsair Gaming Inc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Corsair Gaming Inc trades at $13.63 (market cap $1.42B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 8.9× Corsair Gaming Inc's market cap, and Halozyme Therapeutics Inc. Common Stock is more actively traded (2,179,278 versus 1,160,938). Which is the better fit depends on your goals — on Pluang, investors hold Corsair Gaming Inc for 25 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| CRSR | HALO | |
|---|---|---|
Market Cap | $1.42B | $12.58B |
Volume | 1,160,938 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $14.35 | $115.22 |
52-Week Low | $4.58 | $61.63 |
Typical Hold Time | 25 Days | 1 Days |
Enterprise Value | $1.41B | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRSR trades at $13.09, down 3.68% on the day, with a bullish technical signal from moving averages and recent earnings beats. The company reported Q2 2026 EPS of $0.23, beating estimates of $0.07, and raised full-year guidance. Revenue for 2025 was $1.47B, with a net income margin of 2.53% in 2026 projections. Analyst consensus is a $12.40 price target with a mix of Buy (36%) and Hold (64%) ratings. Recent news includes product launches like the VOXARA microphone and strategic acquisitions.
Outlook is cautiously optimistic due to strong earnings performance and new product initiatives, but risks include competitive pressures in gaming hardware and volatile cash flow trends. The stock's valuation at a P/E of 42.23 may limit near-term upside unless profit growth accelerates. Institutional interest is positive, with Canada Pension Plan adding a position in Q3 2026.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Corsair Gaming Inc
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
